A phase III randomized trial of weight loss to reduce cancer-related fatigue among overweight and obese breast cancer patients: MEDEA Study design

BACKGROUND: Elevated body mass index (BMI) represents a risk factor for cancer-related fatigue (CRF). Weight loss interventions are feasible and safe in cancer survivors, leading to improved cardio-metabolic and quality of life (QOL) outcomes and modulating inflammatory biomarkers. Randomized data a...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Meglio, Antonio, Martin, Elise, Crane, Tracy E., Charles, Cecile, Barbier, Aude, Raynard, Bruno, Mangin, Anthony, Tredan, Olivier, Bouleuc, Carole, Cottu, Paul H., Vanlemmens, Laurence, Segura-Djezzar, Carine, Lesur, Anne, Pistilli, Barbara, Joly, Florence, Ginsbourger, Thomas, Coquet, Bernadette, Pauporte, Iris, Jacob, Guillemette, Sirven, Aude, Bonastre, Julia, Ligibel, Jennifer A., Michiels, Stefan, Vaz-Luis, Ines
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896231/
https://www.ncbi.nlm.nih.gov/pubmed/35246219
http://dx.doi.org/10.1186/s13063-022-06090-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896231/
https://www.ncbi.nlm.nih.gov/pubmed/35246219
http://dx.doi.org/10.1186/s13063-022-06090-6

Ejemplares similares